The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Moore Blatch LLP

Work 023 8071 8000
Fax 023 8033 2205
London, Lymington, Richmond, Southampton

Tim Spring

Moore Blatch LLP

Work Department

Clinical negligence


Tim is a partner and head of clinical negligence. He specialises in complex claims involving death and serious neurological injury, including injury arising out of obstetric mis-management.

South East: Insurance

Clinical negligence: claimant

Within: Clinical negligence: claimant

The 'thriving' clinical negligence practice of Moore Blatch LLP meets a 'consistently high standard with thorough and thoughtful work' and consists of 'highly qualified and experienced individuals'. Its range of expertise includes obstetrics, cauda equina, cerebral palsy, infectious brain diseases, neurosurgery, amputations and endocrinological conditions. The team can also refer individuals to the integrated healthcare, community care and education law teams concerning catastrophically injured children matters. Noted members include 'efficient' practice lead Tim Spring , 'intelligent and organised' cauda equina solicitor Maya Sushila and 'outstanding' partner Paula Barnes, who is 'in a league of her own in terms of the affection of her clients, her ability to turn around the most difficult cases and her ability to engage with experts'. In Richmond, clients further recommend partner Sarah Stanton, who 'is an excellent representative and leaves no stone unturned', as well as senior solicitor and 'safe pair of hands' Sarmad Gassoub and associate Mala Sidebottom, who 'has great empathy with clients and a good medical background'.

[back to top]

South East: Public sector


Within: Education

Moore Blatch LLP has niche expertise in assisting parents and families with issues concerning children with special educational needs, and has a track record of involvement in a number of landmark High Court and Court of Appeal cases. The education team works closely with the firm's personal injury, clinical negligence and community care teams to ensure children with special educational needs are identified early and supported in appropriate areas. Erin Smart heads the team and has a track record in SEN tribunal claims. Clinical negligence practice head Tim Spring is also recommended.

[back to top]


Within: Health

Moore Blatch LLP's 'excellent' healthcare practice is praised for its 'very good, sound understanding of this complex area of law' and its willingness to go 'above and beyond in providing holistic advice to clients'. The practice acts for individuals and their representatives in issues where they require access to health and social care services from the NHS or local authorities. The 'absolutely excellent' Paula Barnes heads the practice and is noted for her track record in administrative and public law matters, as well as for her advice to charities and education centres. Tim Spring Is the name to note for clinical negligence matters. On the up-and-coming front, Mea Fyfe is 'an excellent lawyer who goes above and beyond for her clients'.

[back to top]

Back to index

Legal Developments by:
Moore Blatch LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Foyen has advised Mandalay Resources in 32 Million USD share issue

    Foyen has advised Canadian mining company Mandalay Resources Corporation inits marketed public offering of shares (subscription rights) on the Toronto stock exchange for aggregate gross proceeds of 43 million CAD (32 MUSD).Mandalay is the 100 % owner of the Bjorkdal gold mine in northern Sweden and the transaction has required legal opinions regarding all companies and permits in the Swedish business operation.
  • Foyen recruits lawyer from the Court of Appeal

    Foyen Advokatfirma has recruited lawyer Erika Stjärnström from the Göta Court of Appeal. Erika has joined the law firm's Construction business sector, writes Foyen in a press release .

    Aziz Rahman considers why we may see an increase inunexplained wealth orders (UWO’s) and the implications for law enforcement and individuals.
  • AVELLUM advises on IBRD-supported financing for Ukraine

    AVELLUM acted as the Ukrainian legal counsel to the Ministry of Finance of Ukraine in connection with two syndicated EUR-denominated facilities arranged by Deutsche Bank in December 2018 and March 2019 for the total amount equivalent to approximately USD1 billion.
  • AVELLUM advises EBRD and BSTDB on financing of one of largest solar projects in Ukraine

    AVELLUM acted as the Ukrainian legal counsel to the European Bank for Reconstruction and Development (‚ÄúEBRD ‚ÄĚ) and the Black Sea Trade and Development Bank (" BSTDB ") in connection with senior secured loans in the total amount of up to EUR36.3 million to Rengy Bioenergo LLC (‚ÄúLoans ‚ÄĚ).
  • Gulbenkian Andonain discuss NEW Tier 1 Start-Up Visa and the NEW Tier 1 Innovator Visa

    The document entitled "Statement of Changes to Immigration Rules" which was released by the House of Commons on the 7th March 2019, outlined and advised us on a number of changes that will come into place that will affect the Tier 1 Investor Visa amongst other visa programmes and schemes. The latest article on our website discusses both of these new UK business visa routes. Our immigration lawyers London are already up to date on all of the required information for both the NEW Tier 1 Start-Up Visa and the NEW Tier 1 Innovator Visa .
  • Upcoming Changes to the UK Tier 1 Investor Visa

    According to the new document from the House of Commons on March 7th 2019 titled ‚ÄúStatement of Changes to Immigration Rules‚ÄĚ, a number of changes will come into place that affecting the Tier 1 UK Investor Visa programme amongst other visa programmes and schemes. Read about them in our latest¬† article .¬†
  • Illegal advertisement of effect of a medicinal product

    It is illegal to advertise a specific effect attributed to a medicinal product if said effect is based merely on laboratory tests and has not been demonstrated in relation to humans.
  • Brexit and non-EU Immigration

    There is no doubt that the UK has to date benefited immensely from visa-free EU immigration to the extent that visa conditions and caps on non-EU migrant have undermined and overshadowed the ability of this group to play a prominent role in British industry and commerce and in its expanding and overburdened NHS service. It is the view of  Gulbenkian Andonian  however, that after  Brexit, there should be a noticeable change in those skilled non-EU migrants contributing to British society in a meaningful way. 
  • Gulbenkian Andonian Solicitors discuss Post Brexit scenarios - EU Nationals and Salient Immigration

    From 1 January 2021 everyone except for British and Irish citizens will be subject to immigration control in the UK.   Gulbenkian Andonian solicitors has already published an article on this topic of post- Brexit immigration and has discussed the case of EU nationals and family members after Brexit, you can find that article here as one of many in our blog .